HealthcareServices

ADME Toxicology Testing Market Outlook: Growth and Forecast Highlights 2030

February 19, 2026February 24, 2026 by Marketing Posting

Uncover key drivers, emerging technologies, and competitive movements shaping the adme toxicology testing market from 2026–2035 with trusted insights from The Business Research Company

What level of growth is expected in the ADME Toxicology Testing Market between 2026 and 2030?

The adme toxicology testing market size has recently experienced significant expansion. It is projected to grow from $11.5 billion in 2025 to $12.83 billion in 2026, exhibiting a compound annual growth rate (CAGR) of 11.6%. In the historic period, this growth was primarily driven by factors including the limited availability of automated adme testing systems, a reliance on traditional biochemical assays, an increasing regulatory focus on drug safety, growing pharmaceutical research initiatives, and the adoption of LC-MS and HPLC instruments.

The adme toxicology testing market is projected for significant expansion in the coming years. It is set to reach $20.25 billion by 2030, exhibiting a compound annual growth rate (CAGR) of 12.1%. This growth during the forecast period can be attributed to the development of integrated adme platforms, the rising application of omics and molecular imaging technologies, increasing investment in predictive toxicology software, the expansion of adme testing into the cosmetics and food industries, and the adoption of AI-driven risk assessment solutions. Major trends anticipated over this period include the growing adoption of high-throughput screening instruments, an increasing use of cell-based and in vitro assays, rising demand for omics-based toxicology technologies, the expansion of adme testing in pharmaceutical development, and the integration of simulation and modeling software in risk assessment.

Access Your Free Sample Report for In-Depth Market Insights:

https://www.thebusinessresearchcompany.com/sample.aspx?id=11922&type=smp

Which Drivers Are Expected To Impact The ADME Toxicology Testing Market During The Forecast Period?

The increasing need for new pharmaceutical substances is anticipated to boost the expansion of the ADME toxicology testing market in the future. Novel drugs are defined as pharmaceutical compounds not previously sanctioned or sold for medical applications. ADME toxicity testing constitutes a vital phase in drug development, guaranteeing the safety of these novel drugs and confirming they do not generate adverse toxins within the body. For example, as reported in January 2024 by the Center for Drug Evaluation and Research (CDER), a US-based division of the U.S. Food and Drug Administration (FDA), in their New Drug Therapy Approvals 2023 report, the CDER sanctioned 55 novel drugs in 2023, of which 20 (36%) were categorized as first-in-class, an increase from 37 novel drug approvals in 2022. Consequently, the growing demand for novel drugs is fueling the growth of the ADME toxicology testing market. The expansion of the pharmaceutical industry is projected to advance the ADME toxicology testing market in the coming years. The pharmaceutical industry encompasses a segment dedicated to the identification, formulation, and manufacturing of drugs and medications by both public and private organizations. ADME toxicology testing is employed by this industry to determine the absorption, distribution, metabolism, and excretion (ADME) characteristics of potential drug compounds and to gauge their possible toxicity. This assessment is vital for foreseeing a drug’s actions within the human system, including its rates of absorption, dissemination to specific tissues, metabolic processes, and removal from the body. As an illustration, in June 2023, the European Federation of Pharmaceutical Industries and Associations (EFPIA), a Belgium-based trade group representing the European pharmaceutical industry, reported that Europe’s overall pharmaceutical output reached €390,000 million ($422,803 million) in 2023, an increase from €363,300 million ($393,857 million) in 2022. Consequently, the expanding pharmaceutical industry is propelling the ADME toxicology testing market’s growth.

Which Segments Are Driving Activity In The ADME Toxicology Testing Market?

The adme toxicology testing market covered in this report is segmented –

1) By Product Type: Instruments, Software Solutions, Assays Systems, Reagents, Other Product Types

2) By Method: Cellular Assay, Biochemical Assay, In Silica, Ex-Vivo

3) By Technology: Cell Culture, High Throughput, Molecular Imaging, OMICS Technology, Other Technologies

4) By Application: Systemic Toxicity, Renal Toxicity, Hepatotoxicity, Neurotoxicity, Other Applications

5) By End-User: Cosmetics And Household Products, Pharmaceutical Industry, Animal Industry, Food Industry, Other End Users

Subsegments:

1) By Instruments: High-Throughput Screening Instruments, LC-MS Or MS (Liquid Chromatography-Mass Spectrometry), HPLC (High-Performance Liquid Chromatography), Automated Workstations

2) By Software Solutions: Data Management Software, Simulation And Modeling Software, Risk Assessment Software

3) By Assay Systems: Cell-Based Assays, In Vitro Assays, Bioanalytical Assays

4) By Reagents: Biochemicals, Buffer Solutions, Culture Media

5) By Other Products: Kits And Consumables, Analytical Standards

What Industry Trends Are Transforming The ADME Toxicology Testing Market?

Leading companies within the ADME toxicology testing market are implementing advanced technologies, such as the Cyprotex e-Store, to enable online ordering of ADME-Tox services. The primary goal of ADME-Tox services is to save development costs and time, minimize the chance of failure in later stages, and facilitate the selection of the most promising candidate for clinical development. For example, in October 2023, Evotec SE, a Germany-based biotechnology company, launched the Cyprotex e-Store. This e-commerce platform provides simplified online access to the company’s wide array of ADME-Tox services. The e-Store streamlines and speeds up the acquisition process, letting registered users assess and order Cyprotex’s offerings continuously, twenty-four hours a day, seven days a week. It offers immediate online access to prices and comprehensive protocols, allowing users to effortlessly place orders, track their status, and reorder when necessary. This efficient platform shortens the lead time for services, enabling users to receive their data more quickly.

Which Major Industry Participants Are Leading The ADME Toxicology Testing Market Growth?

Major companies operating in the adme toxicology testing market are AbbVie Inc., Thermo Fisher Scientific Inc., Boehringer Ingelheim GmbH, Laboratory Corporation of America Holdings, Corning Incorporated, Eurofins Scientific SE, Agilent Technologies Inc., Lonza Group AG, Dassault Systèmes SE, Catalent Inc., Charles River Laboratories International Inc., Beckman Coulter Inc., PerkinElmer Inc., Bio-Rad Laboratories Inc., Curia Global Inc, Promega Corporation, Takara Bio Inc, AB Sciex LLC, QPS Holdings LLC, Simulations Plus Inc., Cyprotex, XenoTech LLC, BioIVT LLC, Absorption Systems, Creative Bioarray, SOLVO Biotechnology Rt., Creative Biolabs Inc, Gentronix Limited, Admecell Inc., Molecular Discovery Ltd.

Access The Complete Report For Deeper Market Insights:

https://www.thebusinessresearchcompany.com/report/adme-toxicology-testing-global-market-report

Which Region Is Expected To Experience The Fastest Growth In The ADME Toxicology Testing Market?

North America was the largest region in the ADME toxicology testing market in 2025. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the adme toxicology testing market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

Request Your Customized ADME Toxicology Testing Market Research Report for Competitive Advantage:

https://www.thebusinessresearchcompany.com/customise?id=11922&type=smp

Browse Through More Reports Similar to the Global ADME Toxicology Testing Market 2026, By The Business Research Company

In Vitro Toxicology Testing Market Report 2026

https://www.thebusinessresearchcompany.com/report/in-vitro-toxicology-testing-global-market-report

Pharma Admet Testing Market Report 2026

https://www.thebusinessresearchcompany.com/report/pharma-admet-testing-global-market-report

Genetic Toxicology Testing Market Report 2026

https://www.thebusinessresearchcompany.com/report/genetic-toxicology-testing-global-market-report

Get in touch with us:

The Business Research Company: https://www.thebusinessresearchcompany.com/

Americas +1 310-496-7795